CVS Health Corporation (CVS) Sees Higher Price Target Despite PBM Pressures

CVS Health Corporation (NYSE:CVS) is among the cheap healthcare stocks to buy heading into 2026. On December 4, Bernstein SocGen Group lifted the price target on CVS Health Corporation (NYSE:CVS) to $86.00 from $77.00, while reaffirming a ‘Market Perform’ rating on the stock. The firm attributed the improved guidance to the company’s Aetna business unit, while acknowledging lingering pressures in its Pharmacy Benefit Manager (PBM) segment. According to Bernstein, CVS Health Corporation (NYSE:CVS) is “exec ...